Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 1:13 PM
Ignite Modification Date:
2025-12-25 @ 12:24 PM
NCT ID:
NCT01569295
Group ID:
EG000
Title:
Idelalisib + Bendamustine + Rituximab
Description:
Idelalisib 150 mg tablet administered orally twice daily (until the earliest of participant withdrawal from study, definitive progression of CLL, intolerable toxicity, pregnancy, substantial noncompliance with study procedures, or study discontinuation) + rituximab 375 mg/m\^2 on Day 1, then 500 mg/m\^2 every 28 days administered intravenously for a total of 6 infusions + bendamustine 70 mg/mg\^2/infusion on days 1 and 2 of each 28 day cycle, administered intravenously for a total of 6 cycles (12 infusions).
Deaths Number Affected:
89
Deaths Number At Risk:
None
Serious Number Affected:
152
Serious Number At Risk:
207
Other Number Affected:
199
Other Number At Risk:
207
Study:
NCT01569295
Results Section:
NCT01569295
Adverse Events Module:
NCT01569295